Population Sampling and in vitro Modeling of a 25bp Deletion in MYBPC3 Associated With Hypertrophic Cardiomyopathy A. B. Chowdry1, M. A. Mandegar2, G. M. Benton1, B. T. Naughton1, B. R. Conklin2! 1 23andMe,

First Page		Document Content
Date: 2012-11-08 13:24:38 Health Myosin binding protein C cardiac Genetics Cardiovascular disease Cardiology Induced pluripotent stem cell 23andMe Sudden cardiac death Biology Cardiomyopathy Hypertrophic cardiomyopathy		Population Sampling and in vitro Modeling of a 25bp Deletion in MYBPC3 Associated With Hypertrophic Cardiomyopathy A. B. Chowdry1, M. A. Mandegar2, G. M. Benton1, B. T. Naughton1, B. R. Conklin2! 1 23andMe, Add to Reading List Source URL: blog.23andme.com Download Document from Source Website File Size: 1,24 MB Share Document on Facebook

	Downloaded on February 10, 2014. The Journal of Clinical Investigation. More information at www.jci.org/articles/viewTechnical advance 5′RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy DocID: 1vq4Q - View Document
	Practice Based Evidence for Treatment of Pregnancy and Anthracycline Cardiomyopathy JEAN-BERNARD DURAND, M.D., FCCP, FACC,FACP,FHFSA,FAHA PROFESSOR OF MEDICINE DocID: 1vjaw - View Document
	Impella Assisted Cesarean Delivery in aWeeks Gestation 30 Year Old Female with Newly Diagnosed Cardiomyopathy & Multifocal Incessant Ventricular Tachycardia DocID: 1v7Uk - View Document
	Worse Outcomes in Younger Women with Peripartum Cardiomyopathy Madeline Mahowald, MD J Ryan Scott, MPH, CPH Nivedita Basu, MD DocID: 1uyEc - View Document
	PDF Document DocID: 1rj01 - View Document